0001209191-21-028189.txt : 20210423 0001209191-21-028189.hdr.sgml : 20210423 20210423192702 ACCESSION NUMBER: 0001209191-21-028189 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210421 FILED AS OF DATE: 20210423 DATE AS OF CHANGE: 20210423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Garfield Greg Shaw CENTRAL INDEX KEY: 0001594406 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40337 FILM NUMBER: 21851090 MAIL ADDRESS: STREET 1: C/O SEMLER SCIENTIFIC, INC. STREET 2: 2330 NW EVERETT ST. CITY: PORTLAND STATE: OR ZIP: 97210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroPace Inc CENTRAL INDEX KEY: 0001528287 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 223550230 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 N. BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6502372700 MAIL ADDRESS: STREET 1: 455 N. BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-21 0 0001528287 NeuroPace Inc NPCE 0001594406 Garfield Greg Shaw 368 EAST CAMPBELL AVENUE SUITE 200 CAMPBELL CA 95008 1 0 0 0 Common Stock 2021-04-21 4 P 0 13235 17.00 A 38853 D Stock Option (Right to Buy) 17.00 2021-04-21 4 A 0 21698 0.00 A 2031-04-20 Common Stock 21698 21698 D Reflects shares purchased from the underwriters in the Companys initial public offering. 1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021. /s/ Mark B. Weeks, Attorney-in-Fact 2021-04-23